# 119-hr-2756: National Biotechnology Initiative Act of 2025 119-hr-2756, National Biotechnology Initiative Act of 2025, is a 119th Congress bill sponsored by Rep. Bice, Stephanie I. [R-OK-5] (R-OK); status introduced; PRIA reads it as touching household money (as of 2026-09-21). - Canonical: https://policyrisk.com/legislation/119-hr-2756 - As of: 2026-09-21 - Plain-text twin of the page above; the HTML and this file carry the same facts. ## Facts - Bill: 119-hr-2756 - Congress: 119 - Title: National Biotechnology Initiative Act of 2025 - Status: introduced - Introduced: 2025-04-09 - Sponsor: Rep. Bice, Stephanie I. [R-OK-5] (R-OK) - Cosponsors: 23 - Policy area: Health - Touches household money: yes - Last recorded action: 2026-09-21 ## Summary **Creates a White House-led National Biotechnology Initiative** to coordinate federal R&D, regulatory pathways, data infrastructure, biosafety, and workforce efforts across agencies. It sets up an Office, an Interagency Committee, and a public website to centralize biotech activities and speed commercialization while addressing national security and data standards. - Researchers and industry: Establishes a National Biotechnology Coordination Office and an interagency committee to align funding priorities, create a national network of testbeds, and publish clear regulatory pathways and a single digital portal for multi-agency reviews. This aims to ease commercialization and reduce regulatory overlap. - Workforce and education: Requires coordinated workforce planning, fellowships, curriculum development, reskilling, and federal training to grow domestic biotech talent and prepare federal, academic, and industrial workers for biomanufacturing and computational biology jobs. - Public safety and policy: Directs agencies to strengthen biosafety, biosecurity, and biological data standards, assess foreign investment risks, and produce a national biotechnology strategy with GAO reviews starting within 3 years and repeating every 5 years through year 20. *Authorizes about $132.0 million to the National Science Foundation for administrative support over FY2026–2030 and creates coordinated agency duties that may lead to additional federal costs.* ## Cosponsors (23) - Rep. Khanna, Ro [D-CA-17] (D-CA), 2025-04-09T00:00:00.000Z - Rep. Houlahan, Chrissy [D-PA-6] (D-PA), 2025-04-29T00:00:00.000Z - Rep. Morelle, Joseph D. [D-NY-25] (D-NY), 2025-06-03T00:00:00.000Z - Rep. Auchincloss, Jake [D-MA-4] (D-MA), 2025-06-25T00:00:00.000Z - Rep. Sessions, Pete [R-TX-17] (R-TX), 2025-06-26T00:00:00.000Z - Rep. Bilirakis, Gus M. [R-FL-12] (R-FL), 2025-07-22T00:00:00.000Z - Rep. Vindman, Eugene Simon [D-VA-7] (D-VA), 2025-09-03T00:00:00.000Z - Rep. Flood, Mike [R-NE-1] (R-NE), 2025-09-30T00:00:00.000Z - Rep. Landsman, Greg [D-OH-1] (D-OH), 2025-09-30T00:00:00.000Z - Rep. Miller, Max L. [R-OH-7] (R-OH), 2025-10-03T00:00:00.000Z - Rep. Baird, James R. [R-IN-4] (R-IN), 2025-10-31T00:00:00.000Z - Rep. Neguse, Joe [D-CO-2] (D-CO), 2025-11-19T00:00:00.000Z - Rep. McClain Delaney, April [D-MD-6] (D-MD), 2025-11-25T00:00:00.000Z - Del. Moylan, James C. [R-GU-At Large] (R-GU), 2026-01-13T00:00:00.000Z - Rep. Davis, Donald G. [D-NC-1] (D-NC), 2026-02-09T00:00:00.000Z - Rep. Riley, Josh [D-NY-19] (D-NY), 2026-02-09T00:00:00.000Z - Rep. Whitesides, George [D-CA-27] (D-CA), 2026-04-15T00:00:00.000Z - Rep. Bera, Ami [D-CA-6] (D-CA), 2026-04-16T00:00:00.000Z - Rep. LaLota, Nick [R-NY-1] (R-NY), 2026-04-29T00:00:00.000Z - Rep. Budzinski, Nikki [D-IL-13] (D-IL), 2026-05-15T00:00:00.000Z - Rep. Sorensen, Eric [D-IL-17] (D-IL), 2026-06-02T00:00:00.000Z - Rep. Finstad, Brad [R-MN-1] (R-MN), 2026-06-29T00:00:00.000Z - Rep. Ross, Deborah K. [D-NC-2] (D-NC), 2026-06-30T00:00:00.000Z ## Provisions PRIA read - Biotech training and fellowships for workers: benefit, medium. Agencies would fund biotech education, training, and entrepreneurship programs. Competitive grants would support graduate students and postdocs who do some biotech research in an industry setting. Veterans and industry workers would be able to get re-skilling and upskilling. - More help for biotech startups: benefit, medium. Agencies would give industry, colleges, and nonprofits access to advanced federal labs, equipment, materials, and secure high-performance computing, as appropriate. Agencies would also use SBIR and STTR programs to back biotech proof-of-concept work and new startup formation. This could lower lab a… - Biotech national plan and audits: benefit, medium. The Director and an interagency group would send Congress an annual report starting within 1 year and every year after. They would publish a national biotechnology strategy within 2 years and update it at least every 5 years, including a 5-year budget estimate for urgent actions. The Government Acc… - White House biotech office and portal: benefit, medium. Within 180 days, the President would set up a National Biotechnology Coordination Office in the White House and name a Director. Within 540 days, the office would publish one public biotech website with a dashboard, funding notices, plain-language guides, a Q&A, and past regulatory decisions. It wo… - Five-year funding to run initiative: benefit, medium. The bill would authorize NSF to support the initiative’s staff and operations. It would authorize $22 million for FY2026, $35 million for FY2027, and $25 million each year for FY2028 through FY2030. Funds would cover employees, details, space, and overhead for the White House biotech office. Congre… - Incentives to retool factories for biotech: benefit, medium. Agencies would offer incentives to owners of industrial sites to convert facilities for biotech manufacturing. This would help cover some costs to pivot existing plants to make biotech products and scale up production. - Office winds down in 20 years: mixed, low. Twenty years after enactment, the White House biotech office would transfer most authorities, staff, and resources to other agencies. It would keep enough staff to serve as the executive secretariat and maintain the initiative website. Requirements and powers would carry over to the receiving agenc… ## Related bills - 119-hr-1262: Mikaela Naylon Give Kids a Chance Act - 119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025 - 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act - 119-hr-2102: Major Richard Star Act - 119-hr-2048: Metastatic Breast Cancer Access to Care Act - 119-hr-6130: ASAP Act ## Sources - [119-hr-2756 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/2756) ## Related - [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262) - [119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025](https://policyrisk.com/legislation/119-hr-3514) - [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842) - [119-hr-2102: Major Richard Star Act](https://policyrisk.com/legislation/119-hr-2102) - [119-hr-2048: Metastatic Breast Cancer Access to Care Act](https://policyrisk.com/legislation/119-hr-2048) - [119-hr-6130: ASAP Act](https://policyrisk.com/legislation/119-hr-6130) - [All bills in Congress](https://policyrisk.com/legislation) Source: PRIA, https://policyrisk.com/legislation/119-hr-2756 (as of 2026-09-21).